FFR-guided PCI shows cost-effectiveness when compared to medical therapy for stable CAD

Results of the FAME 2 Cost-Effectiveness Trial Presented at TCT 2012

2012-10-25

(Press-News.org) MIAMI, FL – OCTOBER 24, 2012 –A strategy of up-front percutaneous coronary intervention (PCI) for lesions confirmed to be obstructive by fractional flow reserve (FFR) was shown to be cost-effective in terms of quality-adjusted life years when compared to medical therapy alone. Results of the Cost-Effectiveness sub study of the FAME 2 trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

Fractional flow reserve (FFR) is a physiological index that determines the severity of blood flow blockages in the coronary arteries. An FFR measurement helps physicians to better identify if a specific coronary lesion is truly resulting in a reduction in blood flow.

The FAME 2 trial, a multicenter, international, randomized study, showed that FFR-guided percutaneous coronary intervention (PCI) improved clinical outcomes when compared with optimal medical therapy (OMT) in patients with stable coronary artery disease (CAD). The economic and quality of life implications of this strategy were presented at TCT.

Researchers found that while up-front PCI of FFR-positive lesions is more expensive than medical therapy, the cost-effectiveness of this approach was comparable to other widely accepted medical therapies when quantified in terms of quality-adjusted life years (QALY). At 12 months, the cost of FFR-guided up-front PCI was $2,508 more expensive than medical therapy, but due to quality of life improvements observed with PCI, the overall cost-effectiveness of up-front PCI was $53,000 per quality-adjusted life year. The three-year projected cost for the FFR-guided PCI approach was $32,000 per quality-adjusted life year.

"FFR-guided percutaneous coronary intervention has a higher initial cost than medical therapy," said lead investigator, William F. Fearon, MD. Dr. Fearon is an Associate Professor of Medicine at Stanford University School of Medicine and Associate Director of Interventional Cardiology at Stanford University Medical Center.

"However, the cost gap narrows more than 50 percent by one year. Since angina and quality of life are significantly improved by PCI, results of this study indicate that FFR-guided PCI appears to be economically attractive in an analysis of cost-effectiveness."

###The results of the FAME 2 Cost-Effectiveness trial will be presented on Wednesday October 24, at 11:20 AM EST in the Main Arena (Hall D) of the Miami Beach Convention Center.

The trial was funded by St. Jude Medical, Inc. Dr. Fearon reported receiving an institutional research grant from St. Jude Medical, Inc.

About CRF The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of the Cardiovascular Research Foundation. TCT gathers leading medical researchers and clinicians from around the world to present and discuss the latest developments in the field.

For more information, visit www.crf.org.

ELSE PRESS RELEASES FROM THIS DATE:

Study confirms benefits of transcatheter aortic valve replacement over 3 years

2012-10-25

MIAMI, FL – OCTOBER 24, 2012 – A study found that transcatheter aortic valve replacement (TAVR) yielded lower mortality rates after three years compared with medical therapy in patients deemed to be ineligible for conventional aortic valve surgery. Results of the PARTNER Cohort B trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. TAVR is the recommended ...

Results of the ISAR-LEFT MAIN 2 trial presented at TCT 2012

2012-10-25

MIAMI, FL – OCTOBER 24, 2012 – A study found that second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions. Results of the ISAR-LEFT MAIN 2 trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Patients undergoing invasive treatment of unprotected left main coronary artery (uLMCA) lesions are often ...

Scientists target bacterial transfer of resistance genes

2012-10-25

CHAMPAIGN, Ill. — The bacterium Streptococcus pneumoniae – which can cause pneumonia, meningitis, bacteremia and sepsis – likes to share its antibiotic-defeating weaponry with its neighbors. Individual cells can pass resistance genes to one another through a process called horizontal gene transfer, or by "transformation," the uptake of DNA from the environment. Now researchers report that they can interrupt the cascade of cellular events that allows S. pneumoniae to swap or suck up DNA. The new findings, reported in the journal PLoS ONE, advance the effort to develop ...

Research findings breathe new life into lung disease

2012-10-25

TORONTO, Oct. 24, 2012--It turns out the muscle cells on the outside of blood vessels have been wrongly accused for instigating lung disease. New research shows that while these muscle cells are responsible for constricting or dilating the blood vessels, they are not responsible for sensing the amount of oxygen that gets to the lungs. That message comes from the endothelial cells – special cells that line the blood vessels – along a "signalling pathway." When a person is low on oxygen, blood vessels throughout the body expand to improve the delivery of this vital molecule ...

Is obesity irreversible? Timing is key in weight loss, U-M research shows

2012-10-25

ANN ARBOR, Mich. — Joint research between the University of Michigan and the Argentina-based National Council of Science and Technology (CONICET) has shed light on one of the most frustrating mysteries of weight loss – why the weight inevitably comes back. A novel animal model showed that the longer mice remained overweight, the more "irreversible" obesity became, according to the new study that appeared online ahead of print Oct.24 in the Journal of Clinical Investigation. Over time, the static, obese state of the mice reset the "normal," body weight set point to ...

Mesh-covered stent helps restoration of blood flow in heart attack patients undergoing PCI

2012-10-25

MIAMI, FL – OCTOBER 24, 2012 – A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty. Results of the MASTER trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and will appear in the November 6th issue of the Journal of the American College of Cardiology. Sponsored by the Cardiovascular Research Foundation, ...

Knee replacement not an 'easy solution' for obese patients

2012-10-25

ROSEMONT, IL–Obese patients have a greater risk of complications following total knee replacement surgery, including post-surgical infections, according to a new literature review recently published in the Journal of Bone and Joint Surgery (JBJS). Because of complications, obese patients are more likely to require follow-up surgery (revision). Obesity is reaching epidemic proportions, particularly in the United States, and is a well-documented risk factor for the development of osteoarthritis. Arthritis is initially treated nonsurgically, but total joint replacement often ...

Ghost busting

2012-10-25

The fourth installment of the Paranormal Activity films topped the box office last week. Television channel SyFy's hit show Ghost Hunters scares up big ratings, and has spawned copycat series on networks ranging from Biography to Animal Planet. The omnipresence of paranormal entertainment piqued the interest of Paul Brewer, professor of communication, who wondered what makes viewers believe—or disbelieve— what they see on the screen. His resulting study, recently published in the journal Science Communication, examines the influence of media messages about paranormal ...

Measuring Table-Top Accelerators’ State-of-the-Art Beams

2012-10-25

Part Two: Slicing through the electron beam Wim Leemans of Berkeley Lab's Accelerator and Fusion Research Division heads LOASIS, the Laser and Optical Accelerator Systems Integrated Studies, an oasis indeed for students pursuing graduate studies in laser plasma acceleration (LPA). Among the most promising applications of future table-top accelerators are new kinds of light sources, in which their electron beams power free electron lasers. "If our LPA electron bunches had good enough quality for free electron lasers – and were really only femtoseconds long – we should ...

NASA sees Tropical Storm Sandy approaching Jamaica

2012-10-25

NASA satellites are closely monitoring Tropical Storm Sandy in visible and infrared light as it approaches Jamaica. Sandy is now responsible for hurricane and tropical storm warnings and watches from Jamaica to Cuba, the Bahamas and southern Florida. Sandy is expected to become a hurricane before it reaches Jamaica and Cuba. On Oct. 23, 2012 at 1545 UTC (11:45 a.m. EDT), the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument captured a visible image of Tropical Storm Sandy when its center was a couple of hundred miles south of Jamaica. Sandy's clouds filled ...

LAST 30 PRESS RELEASES:

Novel radiation therapy QA method: Monte Carlo simulation meets deep learning for fast, accurate epid transmission dose generation

A 100-fold leap into the unknown: a new search for muonium conversion into antimuonium

A new approach to chiral α-amino acid synthesis - photo-driven nitrogen heterocyclic carbene catalyzed highly enantioselective radical α-amino esterification

Physics-defying discovery sheds new light on how cells move

Institute for Data Science in Oncology announces new focus-area lead for advancing data science to reduce public cancer burden

Korea University College of Medicine successfully concludes the 2025 Lee Jong-Wook Fellowship on Infectious Disease Specialists Program

Girls are happiest at school – for good reasons

Researchers from the University of Maryland School of Medicine discover genetic ancestry is a critical component of assessing head and neck cancerous tumors